This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1nzg
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /><applet load="1nzg" size="450" color="white" frame="true" align="right" spinBox="true" caption="1nzg, resolution 1.60Å" /> '''Crystal structure of...)
Next diff →
Revision as of 21:58, 24 November 2007
|
Crystal structure of A-DNA decamer GCGTA(3ME)ACGC, with a modified 5-methyluridine
Overview
[structure: see text] Oligonucleotides with a novel, 2'-O-[2-[2-(N,N-dimethylamino)ethoxy]ethyl] (2'-O-DMAEOE) modification, have been synthesized. This modification, a cationic analogue of the, 2'-O-(2-methoxyethyl) (2'-O-MOE) modification, exhibits high binding, affinity to target RNA (but not to DNA) and exceptional resistance to, nuclease degradation. Analysis of the crystal structure of a, self-complementary oligonucleotide containing a single 2'-O-DMAEOE, modification explains the importance of charge factors and gauche effects, on the observed antisense properties. 2'-O-DMAEOE modified, oligonucleotides are ideal candidates for antisense drugs.
About this Structure
1NZG is a Protein complex structure of sequences from [1]. Full crystallographic information is available from OCA.
Reference
2'-O-[2-[2-(N,N-dimethylamino)ethoxy]ethyl] modified oligonucleotides: symbiosis of charge interaction factors and stereoelectronic effects., Prhavc M, Prakash TP, Minasov G, Cook PD, Egli M, Manoharan M, Org Lett. 2003 Jun 12;5(12):2017-20. PMID:12790517
Page seeded by OCA on Sun Nov 25 00:06:30 2007
